Cozart is a pioneering developer of drug and alcohol testing solutions, providing advanced diagnostic systems to law enforcement, healthcare, and workplace safety sectors. Renowned for its innovation, Cozart’s proprietary technologies enable rapid, reliable testing with applications ranging from roadside drug testing to monitoring substance abuse in clinical settings.
Cozart
Next generation drug testing equipment
Sector
Lifesciences
YFM investment
£1.4m - 4x return
Investment date(s)
2001, 2004 - 2007
Deal type
Growth Capital
Location
Oxford
"YFM recognised the potential of our business to transform the drug testing market. As well as their investment, YFM introduced a non executive director, whose advice and support was extremely helpful to us as we rapidly scaled up the business."
Key Information
The Business
Why We Invested
YFM Equity Partners invested in Cozart to support its development as a leader in drug and alcohol testing. The partnership focused on enhancing Cozart’s technology, expanding its market reach, and supporting the commercialisation of its solutions.
Growth Story
Under YFM’s ownership, Cozart delivered significant growth and development:
- Expanded its product portfolio, launching advanced diagnostic tools tailored to diverse sectors.
- Secured key contracts with law enforcement agencies and healthcare providers, establishing itself as a trusted supplier.
- Strengthened its leadership team and operational capacity to meet growing demand.
- Increased its presence in international markets, positioning itself as a global player in drug and alcohol testing.
Outcome
YFM successfully exited its investment in Cozart through a trade sale, marking a strong return for investors. The transaction enabled Cozart to continue its growth under new ownership while further advancing its mission to provide innovative diagnostic solutions for critical public health and safety challenges.